Webinar – Lisa Ng – Understanding Infection and Immunity of SARS-CoV-2: from diagnostics to therapies for COVID-19

Monday 15th June 2020 at Online Webinar

SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) is the causative agent of the ongoing Coronavirus Disease 2019 (COVID-19) pandemic. Alongside investigations into the virology of SARS-CoV-2, understanding the fundamental physiological and immunological processes underlying the clinical manifestations of COVID-19 is vital for the identification and rational design of effective therapies. In this webinar, Lisa Ng will provide an overview of the pathophysiology of SARS-CoV-2 infection. She will describe its interaction with the immune system and the subsequent contribution of dysfunctional immune responses to disease progression. These will provide important insights in designing useful diagnostics and therapies.

Since starting her own research lab at the Singapore Immunology Network (SIgN), Lisa Ng is currently a Senior Principal Investigator. The research interest of her group focuses on the immune responses of arthrogenic arboviruses that are epidemic or highly endemic in the tropical region.

The webinar will be moderated by Faith Osier, the President of the International Union of Immunological Societies (IUIS), an Official #TOGETHERBAND Ambassador for the UN Sustainable Development Goal 3: Good Health & Well-being and a 2018 TED Fellow.

Join the webinar: IUIS-Frontiers Webinar Series on COVID-19


Event Details


Upcoming Events

slide 12 to 14 of 6

11th International gamma/delta T Cell Conference

Tuesday 20th May 2025 at Hilton Toronto DowntownAnnouncing the Recipients of the 2024 Travel4Expertise Grant!, IUIS 2025: Empower the Next Generation of Scientists! and 1 more

The Arthur and Sandra Irving Cancer Immunology Symposium

Sunday 22nd June 2025

FOCIS 2025 Annual Meeting

Tuesday 24th June 2025 at Boston Marriott Copley PlaceAnnouncing the Recipients of the 2024 Travel4Expertise Grant!, IUIS 2025: Empower the Next Generation of Scientists! and 1 more